US Patent Issued to Purdue Research Foundation on Sept. 22 for "2,3-disubstituted pyrido[3,4-bpyrazine-containing compounds as kinase inhibitors" (American, Indian Inventors)

Posted On: 2026-09-24

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,962, issued on Sept. 22, was assigned to Purdue Research Foundation (West Lafayette, Ind.). "2,3-disubstituted pyrido[3,4-bpyrazine-contai... Read More

US Patent Issued to STINGRAY THERAPEUTICS on Sept. 22 for "Imidazole compounds as inhibitors of ENPP1" (California, Arizona Inventors)

Posted On: 2026-09-24

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,963, issued on Sept. 22, was assigned to STINGRAY THERAPEUTICS INC. (Houston). "Imidazole compounds as inhibitors of ENPP1" was invented b... Read More

US Patent Issued to Cornell University on Sept. 22 for "Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer" (New York Inventors)

Posted On: 2026-09-24

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,964, issued on Sept. 22, was assigned to Cornell University (Ithaca, N.Y.). "Macrocyclic complexes of alpha-emitting radionuclides and the... Read More

US Patent Issued to SOUTHERN RESEARCH INSTITUTE on Sept. 22 for "Modulators of programmed death-ligand-1" (Alabama Inventors)

Posted On: 2026-09-24

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,965, issued on Sept. 22, was assigned to SOUTHERN RESEARCH INSTITUTE (Birmingham, Ala.). "Modulators of programmed death-ligand-1" was inv... Read More

US Patent Issued to FOGHORN THERAPEUTICS on Sept. 22 for "BRM/BRG1 inhibitors and uses thereof" (Massachusetts Inventors)

Posted On: 2026-09-24

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,966, issued on Sept. 22, was assigned to FOGHORN THERAPEUTICS INC. (Watertown, Mass.). "BRM/BRG1 inhibitors and uses thereof" was invented... Read More

US Patent Issued to NIHON NOHYAKU on Sept. 22 for "Condensed heterocyclic compound having a sulfonamide group or salt thereof, agricultural or horticultural insecticide or animal ectoparasite or endoparasite control agent comprising the compound or the salt thereof, and method for using the compound or the salt thereof, the insecticide, or the control agent" (Japanese Inventors)

Posted On: 2026-09-24

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,967, issued on Sept. 22, was assigned to NIHON NOHYAKU Co. LTD. (Tokyo). "Condensed heterocyclic compound having a sulfonamide group or sa... Read More

US Patent Issued to Prometheus Biosciences on Sept. 22 for "Therapeutic agents targeting GPR35" (California Inventors)

Posted On: 2026-09-24

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,968, issued on Sept. 22, was assigned to Prometheus Biosciences Inc. (San Diego). "Therapeutic agents targeting GPR35" was invented by Rob... Read More

US Patent Issued to Hoffmann-La Roche on Sept. 22 for "Process for the preparation of 2-bromo-4-(3,5-difluorophenyl)-4,5,6,7-tetrahydro-[1,2,4triazolo[1,5-apyrimidine" (Chinese Inventors)

Posted On: 2026-09-24

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,969, issued on Sept. 22, was assigned to Hoffmann-La Roche Inc. (Branchburg, N.J.). "Process for the preparation of 2-bromo-4-(3,5-difluor... Read More

US Patent Issued to THRYV THERAPEUTICS on Sept. 22 for "Pyrazolo[3,4-dpyrimidin-6-yl-sulfonamide derivatives for the inhibition of SGK-1" (Canadian, American Inventors)

Posted On: 2026-09-24

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,970, issued on Sept. 22, was assigned to THRYV THERAPEUTICS INC. (Montreal). "Pyrazolo[3,4-dpyrimidin-6-yl-sulfonamide derivatives for the... Read More

US Patent Issued to AstraZeneca on Sept. 22 for "Certain 2,5-diazabicyclo[4.2.0octanes and octahydrofuro[3,4-bpyrazines as GLP-1 receptor modulators" (Swedish Inventors)

Posted On: 2026-09-24

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,971, issued on Sept. 22, was assigned to AstraZeneca AB (Sodertalje, Sweden). "Certain 2,5-diazabicyclo[4.2.0octanes and octahydrofuro[3,4... Read More

Exclusive

Category

Source

Publication

Byline

Location

US Patent Issued to Purdue Research Foundation on Sept. 22 for "2,3-disubstituted pyrido[3,4-bpyrazine-containing compounds as kinase inhibitors" (American, Indian Inventors)

US Patent Issued to STINGRAY THERAPEUTICS on Sept. 22 for "Imidazole compounds as inhibitors of ENPP1" (California, Arizona Inventors)

US Patent Issued to Cornell University on Sept. 22 for "Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer" (New York Inventors)

US Patent Issued to SOUTHERN RESEARCH INSTITUTE on Sept. 22 for "Modulators of programmed death-ligand-1" (Alabama Inventors)

US Patent Issued to FOGHORN THERAPEUTICS on Sept. 22 for "BRM/BRG1 inhibitors and uses thereof" (Massachusetts Inventors)

US Patent Issued to Prometheus Biosciences on Sept. 22 for "Therapeutic agents targeting GPR35" (California Inventors)

US Patent Issued to Hoffmann-La Roche on Sept. 22 for "Process for the preparation of 2-bromo-4-(3,5-difluorophenyl)-4,5,6,7-tetrahydro-[1,2,4triazolo[1,5-apyrimidine" (Chinese Inventors)

US Patent Issued to THRYV THERAPEUTICS on Sept. 22 for "Pyrazolo[3,4-dpyrimidin-6-yl-sulfonamide derivatives for the inhibition of SGK-1" (Canadian, American Inventors)

US Patent Issued to AstraZeneca on Sept. 22 for "Certain 2,5-diazabicyclo[4.2.0octanes and octahydrofuro[3,4-bpyrazines as GLP-1 receptor modulators" (Swedish Inventors)